AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 87 filers reported holding AEROVATE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $79,574 | -94.4% | 47,936 | 0.0% | 0.08% | -93.5% |
| Q1 2024 | $1,417,468 | +30.7% | 47,936 | 0.0% | 1.31% | +94.2% |
| Q4 2023 | $1,084,792 | +66.8% | 47,936 | 0.0% | 0.68% | +28.3% |
| Q3 2023 | $650,492 | -20.9% | 47,936 | 0.0% | 0.53% | +0.4% |
| Q2 2023 | $822,102 | -15.0% | 47,936 | 0.0% | 0.52% | -20.2% |
| Q1 2023 | $966,869 | -34.8% | 47,936 | -5.3% | 0.66% | -35.6% |
| Q4 2022 | $1,483,049 | – | 50,616 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 3,758,686 | $111,144,345 | 6.19% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $60,300,593 | 5.56% |
| TCG Crossover Management, LLC | 2,201,274 | $65,091,672 | 5.15% |
| GREAT POINT PARTNERS LLC | 887,690 | $26,248,993 | 4.09% |
| RA Capital Management | 8,263,982 | $244,365,948 | 3.11% |
| Exome Asset Management LLC | 98,485 | $2,912,201 | 2.49% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 110,264 | $3,260,506 | 2.16% |
| Ghost Tree Capital, LLC | 225,000 | $6,653,250 | 1.84% |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $35,627,917 | 1.50% |
| Octagon Capital Advisors LP | 403,685 | $11,936,965 | 1.43% |